首页> 外文期刊>Biotechnology Journal >Development of a vaccine marker technology: Display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination
【24h】

Development of a vaccine marker technology: Display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination

机译:疫苗标记技术的发展:在重组多瘤病毒样五聚体和衣壳的表面显示B细胞表位,可在接种疫苗后诱导仔猪中的肽特异性抗体

获取原文
获取原文并翻译 | 示例
           

摘要

Highly immunogenic capsomers (pentamers) and virus-like particles (VLPs) were generated through insertion of foreign B cell epitopes into the surface-exposed loops of the VP1 protein of murine polyomavirus and via heterologous expression of the recombinant fusion proteins in E. coli. Usually, complex proteins like the keyhole limpet hemocyanin (KLH) act as standard carrier devices for the display of such immunogenic peptides after chemical linkage. Here, a comparative analysis revealed that antibody responses raised against the carrier entities, KLH or VP1 pentamers, did not significantly differ up to 18 weeks, demonstrating the highly immunogenic nature of VP1-based particulate structures. The carrier-specific antibody response was reproducibly detected in the meat juice after processing. More importantly, chimeric VP1 pentamers and VLPs carrying peptides of 12 and 14 amino acids in length, inserted into the BC2 loop, induced a strong and long-lasting humoral immune response against VP1 and the inserted foreign epitope. Remarkably, the epitope-specific antibody response was only moderately decreased when VP1 pentamers were used instead of VLPs. In conclusion, we identified polyomavirus VP1 -based structures displaying surface-exposed immunodominant B cell epitopes as being an efficient carrier system for the induction of potent peptide-specific antibodies. The application of this approach in vaccine marker technology in livestock holding and the meat production chain is discussed.
机译:通过将外源B细胞表位插入鼠类多瘤病毒VP1蛋白的表面暴露环中,以及通过重组融合蛋白在大肠杆菌中的异源表达,产生了高度免疫原性的衣壳异构体(五聚体)和病毒样颗粒(VLP)。通常,复杂的蛋白质(例如匙孔血蓝蛋白(KLH))充当标准载体设备,用于在化学键合后展示此类免疫原性肽。在这里,一项比较分析显示,针对载体实体KLH或VP1五聚体的抗体反应在长达18周的时间内没有显着差异,表明基于VP1的微粒结构具有高度免疫原性。在加工后的肉汁中可再现地检测到载体特异性抗体应答。更重要的是,携带长度为12和14个氨基酸的肽的嵌合VP1五聚体和VLP插入BC2环中,可诱导出针对VP1和插入的异源表位的强烈而持久的体液免疫应答。值得注意的是,当使用VP1五聚体代替VLP时,表位特异性抗体反应仅适度降低。总之,我们确定显示出暴露于表面的免疫优势B细胞表位为基础的多瘤病毒VP1结构为诱导有效的肽特异性抗体的有效载体系统。讨论了该方法在牲畜饲养和肉类生产链中的疫苗标记技术中的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号